Literature DB >> 14718256

Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells.

Vassilis Valatas1, George Kolios, Pinelopi Manousou, George Notas, Costas Xidakis, Ioannis Diamantis, Elias Kouroumalis.   

Abstract

Kupffer cells (KC) and lipopolysaccharide (LPS) interaction is the initial event leading to hepatic inflammation and fibrosis in many types of liver injury. We studied chemokine secretion by KC activated with LPS and the possible effect of the somatostatin analogue octreotide, in the regulation of this process. KC isolated from Sprague-Dawley rats were cultured in the presence of LPS added alone or with different concentrations of octreotide for 24 and 48 h, and chemokine production was assessed in culture supernatants by ELISA. CC chemokine mRNA expression was assessed by semiquantitative RT-PCR. Vehicle-stimulated KC produced a basal amount of CC and CXC chemokines. LPS-stimulated KC secreted significantly increased amounts of IL-8 (GRO/CINC-1) (P<0.001), MIP-2 (P<0.001), MCP-1 (P<0.001), and RANTES (P<0.01). Octreotide inhibited LPS-induced secretion of the CC chemokines MCP-1 (P<0.05) and RANTES (P<0.05), but not the CXC chemokines IL-8 (GRO/CINC-1) and MIP-2, in a concentration-dependent manner. Downregulation of basal and LPS-induced mRNA expression of the CC chemokines was also observed in the presence of octreotide. Pretreatment with phosphatidylinositol 3 (PI3)-kinase inhibitors reduced chemokine production by LPS-treated KC in both the mRNA and protein level. Furthermore, it prevented the octreotide inhibitory effect on LPS-induced chemokine secretion, indicating a possible involvement of the PI3-kinase pathway. In conclusion, these data demonstrate that chemokine secretion by KC can be differentially regulated by octreotide, and suggest that this somatostatin analogue may have immunoregulatory effects on resident liver macrophages. British Journal of Pharmacology (2004) 141, 477-487. doi:10.1038/sj.bjp.0705633

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718256      PMCID: PMC1574216          DOI: 10.1038/sj.bjp.0705633

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  65 in total

Review 1.  Neuropeptides and their receptors in the immune system.

Authors:  P M van Hagen; L J Hofland; A M ten Bokum; E G Lichtenauer-Kaligis; D J Kwekkeboom; D Ferone; S W Lamberts
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

2.  Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C.

Authors:  F Kusano; Y Tanaka; F Marumo; C Sato
Journal:  Lab Invest       Date:  2000-03       Impact factor: 5.662

Review 3.  The role of chemokine receptors in primary, effector, and memory immune responses.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Somatostatin and somatostatin receptors in the immune system: a review.

Authors:  A M ten Bokum; L J Hofland; P M van Hagen
Journal:  Eur Cytokine Netw       Date:  2000-06       Impact factor: 2.737

5.  Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E x cyclin-dependent kinase 2 complexes.

Authors:  D L Medina; M J Toro; P Santisteban
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

6.  Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells.

Authors:  Y Chowers; L Cahalon; M Lahav; H Schor; R Tal; S Bar-Meir; M Levite
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 7.  Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.

Authors:  R J Ulevitch; P S Tobias
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  Somatostatin analogues suppress the inflammatory reaction in vivo.

Authors:  K Karalis; G Mastorakos; G P Chrousos; G Tolis
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.

Authors:  A Kubota; Y Yamada; S Kagimoto; A Shimatsu; M Imamura; K Tsuda; H Imura; S Seino; Y Seino
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Acute alcohol intoxication and gadolinium chloride attenuate endotoxin-induced release of CC chemokines in the rat.

Authors:  M Bukara; A P Bautista
Journal:  Alcohol       Date:  2000-02       Impact factor: 2.405

View more
  10 in total

1.  Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.

Authors:  P Manousou; G Kolios; V Valatas; I Drygiannakis; L Bourikas; K Pyrovolaki; I Koutroubakis; H A Papadaki; E Kouroumalis
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

2.  Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells.

Authors:  Hendrik Reynaert; Krista Rombouts; Yutao Jia; Daniel Urbain; Nirjhar Chatterjee; Naoki Uyama; Albert Geerts
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide.

Authors:  Costas Xidakis; Dushanka Ljumovic; Pinelopi Manousou; George Notas; Vassilis Valatas; George Kolios; Elias Kouroumalis
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 4.  Role of Kupffer cells in the pathogenesis of liver disease.

Authors:  George Kolios; Vassilis Valatas; Elias Kouroumalis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 5.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

Review 6.  Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken.

Authors:  Dimitrios N Samonakis; George Notas; Nikolaos Christodoulakis; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

7.  Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells.

Authors:  George Kolios; Vassilis Valatas; Pinelopi Manousou; Costas Xidakis; George Notas; Elias Kouroumalis
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

8.  Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracil.

Authors:  Leonidas A Bourikas; George Kolios; Vassilis Valatas; George Notas; Ioannis Drygiannakis; Iordanis Pelagiadis; Pinelopi Manousou; Stefanos Klironomos; Ioannis A Mouzas; Elias Kouroumalis
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

9.  Somatostatin analogue, Octreotide, improves restraint stress-induced liver injury by ameliorating oxidative stress, inflammatory response, and activation of hepatic stellate cells.

Authors:  Neven Makram Aziz; Merhan Mamdouh Ragy; Sabreen Mahmoud Ahmed
Journal:  Cell Stress Chaperones       Date:  2018-08-14       Impact factor: 3.667

10.  Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice.

Authors:  Antonino Sgroi; Carmen Gonelle-Gispert; Philippe Morel; Reto Marc Baertschiger; Nadja Niclauss; Gilles Mentha; Pietro Majno; Veronique Serre-Beinier; Leo Buhler
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.